PHARMA LITERATI

Maharashtra government's Medical Education and Drugs Department along with ‘JT Foundation’ has launched " Fight Obesity ", an obesity awareness initiative today. Girish Mahajan, minister for medical education and water resources launched this campaign simultaneously across medical colleges in Maharashtra. The dignitaries at the inaugural function were Dr Jayashree Todkar, Convener of Fight Obesity Campaign & director of JT Foundation, Dr Pravin Shingare, director, Medical Education and Research; Dr Vinayak Kale, Dr Ajay Bhandarwar, head of Department for Laproscopy at J J Hospitals; Dr Nagsen Ramtaje and Dr Saadhik Patel. Under the leadership of chief minister, Devendra Fadnavis who strives to fight the increasing prevalence of obesity and serious lifestyle diseases associated with it. The state government has formed a task force that will work on the awareness correction, prevention, early diagnosis and treatment of the disease. As per recent statistic

A seminar on 'API SYNTHESIS- FROM LEAD OPTIMIZATION TO PATENT FILING' 17th December, 2016 About the Seminar: The aim of this seminar is to enable the participants to successfully exploit their synthetic and medicinal chemistry expertise with the end goal of discovering compounds suitable for progression into human clinical trials. Lectures from reputed experts from industry and academia will include topics related to Process chemistry, Computer - aided drug discovery (CADD) to support Medicinal chemistry. The seminar will further highlight the current scenario of Intellectual Property in Indian Pharmaceutical R&D and US Patent, general IP Awareness & International filing with an industry perspective. This will help to provide deeper insight into every stage of discovery, from target identification to lead optimization to patent filing and help students explore different career avenues in the field of chemistry. Who should attend? * UG/PG/PhD students

Forbes India Recently published a wonderful article about the growth story of Lupin Pharmaceuticals and the role if the leaders Vinita & Nilesh Gupta in this growth. The article mentions as the duo as The Yin and Yang of Lupin. Putting their diverse management styles to work, Vinita and Nilesh Gupta are dreaming big billions for the pharma major. They are the winners of Entrepreneur of the year award for 2016 at the Forbes India Leadership Awards 2016. http://www.forbesindia.com/article/leadership-awards-2016/vinita-nilesh-gupta-the-yin-and-yang-of-lupin/44917/1

Pharmacy Council of India has published Final scheme and syllabus for B. Pharm course implemented from 2016-17. The detailed course can be accessed at http://www.pci.nic.in/CollegesCourses/Syllabus_B_Pharm.pdf We had recently posted about the Final scheme and syllabus for M. Pharm course at http://pharmaliterati.blogspot.in/2016/11/final-scheme-syllabus-for-m-pharm.html

The Indian pharmaceutical sector has the potential to grow to the size of $300 billion by 2030 from the current $15 billion provided it accords high priority on quality and research & development, chief executives of top pharmaceutical companies said. Speaking at a CEO round table organized by CPhI & P- MEC India in Mumbai, the top executives said Indian firms must begin research on precision medicines to capture the global market. “ We must capture the growing biotechnology segment to cash in on the increasing demand for bio-similars ,” said D.G. Shah, Secretary General, Indian Pharmaceutical Association (IPA). Dr Dinesh Dua, MD, Nectar Lifesciences said India must increase its self-reliance for Active Pharmaceutical Ingredients (API) sourcing and has to reduce dependency on China which is dumping API at very low prices making Indian API uncompetitive. “ We must address this concern immediately. We urge the government to set up a separate ministry for the p

The group is likely to prioritize a list of diseases that a larger working group, comprising of representation from the drug regulator and pharmaceutical firms, will focus on before the next meeting. A joint working group (JWG) formed under the aegis of the Indian Council of Medical Research and Sun Pharmaceuticals Ltd, along with experts from International Centre For Genetic Engineering and Biotechnology and All India Institute of Medical Sciences , is planning to propose an overhaul for the drug regulatory system, vaccine development and clinical trials in the country. The initial ideas mooted for updating the drug regulatory system include political support for the Drug Controller General of India’s regulatory framework, making public the decision for rejection or approval of a drug, maintaining timelines for regulatory approvals, regulatory control on data quality and appointment of specialized reviewers of drug process approval. The meeting, conducted on Thursday,

Demonetization has neutral impact on sales of medicines after the first week of government's "bold'' announcement, while a substantial part of consumers also switched to ordering medicines through online pharmacies like PharmEasy and 1mg . While retailers and stockists did not register any dip in sales, e-pharmacies are witnessing a sales spurt of 10-20%, with many consumers stocking up for a month or so, and preponing their medicine purchase. This could also be attributed to the fact that consumers were allowed to buy drugs with banned Rs 500 and Rs 1,000 notes against a prescription. The currencies could also be used at retail stores, as well for cash-on-delivery in online orders. Retail data collated from stockists across the country showed no reduction in their sales, pharmaceutical research firm AIOCD Awacs said. The survey of 350-plus leading stockists across the country, representing over 2% of the organised pharmaceutical market sales, was done to u

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com Invention Application No Inventors Institute In situ gel drug delivery system and a process for preparing the same 205/DEL/2013A 1) Idage Bhaskar Bhairavnath 2) Idage Susheela Bhaskar 3) Bhanudas Shankarrao Kuchekar Council of Scientific & Industrial Research Pharmaceutical compositions for the coordinated delivery of naproxen and lansoprazole 6756/CHE/2014A 1) Vasudha Bakshi 2) Madhu Babu Ananthula 3) Amarachinta Padmanabha Rao Lalitha College of Pha

To increase availability of generic medicines at affordable prices and to promote Jan Aushadhi Scheme, the Pharmacy Council of India (PCI) encourages colleges to establish Jan Aushadhi stores in their premises. This will serve both the purpose of requirement of quality medicine at affordable price as well as the requirement of practical training to the student pharmacists under the provisions of   'the education regulations, 1991' and 'the bachelor of pharmacy course regulation, 2014' . The PCI will extend support by way of pursuance with regulatory bodies like BPPI and state drug control departments for the issuance of licenses to the colleges. The council has also directed the state pharmacy council to provide guidance to the colleges in their respective states. Dr B Suresh, president of PCI says, “ PCI is encouraging pharmacy colleges to establish Jan Aushadhi store in their premises. After issuing the circular of this initiative by the council, many inst

Pharmacy Council of India (PCI) has published final scheme & Syllabus for M. Pharm course implemented from 2016-17 academic sessions. This syllabus is based on notification in the gazette of India no. 362, dated December 11 th 2014. The full text syllabus is available at http://www.pci.nic.in/CollegesCourses/Syllabus_M_Pharm.pdf As pharmabiz reports here: http://www.pharmabiz.com/NewsDetails.aspx?aid=98755&sid=1 The new M Pharm syllabus will be more of practical oriented rather than theory and the students will have an option to work with the industry and get a practical experience along with the stipend. The new syllabus is all set and will appear on the PCI website since November 17, 2016 . The council has assured that the new syllabus will benefit the students as well as the industry. Dr B Suresh, president of PCI says, " The new syllabus of M Pharm is a new approach to postgraduate education. The two-year course will include a theory based educ

Department of Pharmacy, BITS-Pilani would like to invite you to the International Conference on Challenges in Drug Discovery and Delivery (ICCD3) to be held in Birla Institute of Technology and Science Pilani, Rajasthan, India in March 2-4, 2017. The conference will have invited lectures from eminent scientists in the field from around the globe. Further, during this three-day event, the participants will have opportunities to meet network colleagues and present their latest research findings as oral short communications / posters. The future networking opportunities between the research groups will be also discussed. Call for Abstracts: Authors are invited to submit their significant original and unpublished contributions on the topics listed below, but certainly not limited to:  ·          Computer Aided Drug Design ·          Combinatorial Chemistry ·          Phytopharmaceutical/Natural Product Chemistry ·          Pharmacology and Pharmaco-therapeutics ·